The U.S. Preventive Services TaskForce, an independent panel of nongovernment clinicians who provide evidence-based practice guidelines, recommends against screening men over age 75 for prostate cancer.
Ned Calonge, the Colorado doctor who is chairman of the U.S. Preventive Services TaskForce, a government-sponsored expert panel that evaluates preventive tests.